Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
MMWR Morb Mortal Wkly Rep ; 69(39): 1398-1403, 2020 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-33001876

RESUMO

Coronavirus disease 2019 (COVID-19) is a viral respiratory illness caused by SARS-CoV-2. During January 21-July 25, 2020, in response to official requests for assistance with COVID-19 emergency public health response activities, CDC deployed 208 teams to assist 55 state, tribal, local, and territorial health departments. CDC deployment data were analyzed to summarize activities by deployed CDC teams in assisting state, tribal, local, and territorial health departments to identify and implement measures to contain SARS-CoV-2 transmission (1). Deployed teams assisted with the investigation of transmission in high-risk congregate settings, such as long-term care facilities (53 deployments; 26% of total), food processing facilities (24; 12%), correctional facilities (12; 6%), and settings that provide services to persons experiencing homelessness (10; 5%). Among the 208 deployed teams, 178 (85%) provided assistance to state health departments, 12 (6%) to tribal health departments, 10 (5%) to local health departments, and eight (4%) to territorial health departments. CDC collaborations with health departments have strengthened local capacity and provided outbreak response support. Collaborations focused attention on health equity issues among disproportionately affected populations (e.g., racial and ethnic minority populations, essential frontline workers, and persons experiencing homelessness) and through a place-based focus (e.g., persons living in rural or frontier areas). These collaborations also facilitated enhanced characterization of COVID-19 epidemiology, directly contributing to CDC data-informed guidance, including guidance for serial testing as a containment strategy in high-risk congregate settings, targeted interventions and prevention efforts among workers at food processing facilities, and social distancing.


Assuntos
Centers for Disease Control and Prevention, U.S./organização & administração , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Administração em Saúde Pública , Prática de Saúde Pública , COVID-19 , Infecções por Coronavirus/epidemiologia , Humanos , Governo Local , Pneumonia Viral/epidemiologia , Governo Estadual , Estados Unidos/epidemiologia
2.
Int J Biostat ; 14(2)2018 11 22.
Artigo em Inglês | MEDLINE | ID: mdl-30465718

RESUMO

Background Many researchers have studied the relationship between diet and health. Specifically, there are papers showing an association between the consumption of sugar sweetened beverages and Type 2 diabetes. Many meta-analyses use individual studies that do not attempt to adjust for multiple testing or multiple modeling. Hence the claims reported in a meta-analysis paper may be unreliable as the base papers do not ensure unbiased statistics. Objective Determine (i) the statistical reliability of 10 papers and (ii) indirectly the reliability of the meta-analysis study. Method We obtained copies of each of the 10 papers used in a metaanalysis paper and counted the numbers of outcomes, predictors, and covariates. We estimate the size of the potential analysis search space available to the authors of these papers; i. e. the number of comparisons and models available. The potential analysis search space is the number of outcomes times the number of predictors times 2 c , where c is the number of covariates. This formula was applied to information found in the abstracts (Space A) as well as the text (Space T) of each base paper. Results The median and range of the number of comparisons possible across the base papers are 6.5 and (2 12,288), respectively for Space A, and 196,608 and (3072-117,117,952), respectively for Space T. It is noted that the median of 6.5 for Space A may be misleading as each study has 60-165 foods that could be predictors. Conclusion Given that testing is at the 5% level and the number of comparisons is very large, nominal statistical significance is very weak support for a claim. The claims in these papers are not statistically supported and hence are unreliable so the meta-analysis paper is also unreliable.


Assuntos
Interpretação Estatística de Dados , Epidemiologia/normas , Metanálise como Assunto , Fenômenos Fisiológicos da Nutrição , Avaliação de Resultados em Cuidados de Saúde/normas , Humanos
3.
Biostatistics ; 6(1): 157-69, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15618534

RESUMO

Microarray technology is rapidly emerging for genome-wide screening of differentially expressed genes between clinical subtypes or different conditions of human diseases. Traditional statistical testing approaches, such as the two-sample t-test or Wilcoxon test, are frequently used for evaluating statistical significance of informative expressions but require adjustment for large-scale multiplicity. Due to its simplicity, Bonferroni adjustment has been widely used to circumvent this problem. It is well known, however, that the standard Bonferroni test is often very conservative. In the present paper, we compare three multiple testing procedures in the microarray context: the original Bonferroni method, a Bonferroni-type improved single-step method and a step-down method. The latter two methods are based on nonparametric resampling, by which the null distribution can be derived with the dependency structure among gene expressions preserved and the family-wise error rate accurately controlled at the desired level. We also present a sample size calculation method for designing microarray studies. Through simulations and data analyses, we find that the proposed methods for testing and sample size calculation are computationally fast and control error and power precisely.


Assuntos
Interpretação Estatística de Dados , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Tamanho da Amostra , Simulação por Computador , Regulação Leucêmica da Expressão Gênica/fisiologia , Humanos , Leucemia Mieloide Aguda/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética
4.
Sao Paulo; Pioneira; 1977. 423 p. ilus, tab, graf, 22cm.
Monografia em Português | LILACS, HANSEN, Hanseníase, SESSP-ILSLACERVO, SES-SP | ID: biblio-1082966
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA